We appreciate very much the comments about our article concerning the prognosis of Pneumocystis carinii pneumonia (PCP) in patients with AIDS, requiring mechanical ventilation (MV) for acute respiratory failure (ARF).
ically poor and MV may not be justified. These patients must be clearly differentiated from those with inaugural ARF or ARF that begins in the first days of a treatment which has not yet reached efficacy. Such Pneumothorax in AIDS is difficult to manage. In our hemophiliac cohort with 97 patients on aerosolized pentamidine since June 1989, five pneumothoraces could be observed. Two were coincidental with a breakthrough P carinii pneumonia, another occurred without any apparent opportunistic infection during secondary prophylaxis. Another case was the result of cavitating Pseudomonas aeruginosa pneumonia; another pneumothorax during primary prophylaxis could not be attributed to any underlying pulmonary disease and was classified as spontaneous. Although the pleura is a target of P carinii infection in the setting of aerosolized pentamidine prophylaxis, other underlying conditions must be taken into account. Yet recurrences of P carinii pneumonia appear treatable. We, therefore, now recommend an aggressive diagnostic and therapeutic approach in HIVinfected patients with pneumothorax during aerosolized pentamidine prophylaxis. This includes thoracoscopy with inspection of the pleural surfaces, pleural biopsy in case of an altered aspect, and eventually resection of cysts. As Schaumberg et all pointed out, examination of pleural fluid including a stain for P carinji may add further useful diagnostic information. 
